Kanya Rajangam - Jan 14, 2022 Form 4 Insider Report for Nkarta, Inc. (NKTX)

Role
Chief Medical Officer
Signature
/s/ Alicia Hager, as Attorney-in-Fact
Stock symbol
NKTX
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 03:52 PM
Previous filing
Aug 9, 2021
Next filing
Jul 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NKTX Common Stock Award $0 +12.8K $0.00 12.8K Jan 14, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTX Stock Option (right to buy) Award $0 +76.8K $0.00 76.8K Jan 14, 2022 Common Stock 76.8K $12.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") which vest in four equal annual installments beginning on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of Common Stock of the Issuer.
F2 This option is scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following January 14, 2022.